Application 209847

Type
NDA
Sponsor
MYLAN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DARUNAVIR AND RITONAVIRDARUNAVIR AND RITONAVIRTABLET; ORAL400MG/50MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77143ORIG 2023-12-27